Cipla | CIPLA - Ebit

Stock Price
1,326.50
Daily Change
-14.60 -1.09%
Monthly
1.03%
Yearly
-10.17%
Q1 Forecast
1,315.62

Cipla reported INR9.77B in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Arca Biopharma USD -25.09M 5.23M Mar/2025
aTyr Pharma USD -226.49K 140.85K Sep/2025
Bio Path USD -3.24M 616K Mar/2025
Brainstorm Cell Therapeutics USD -3.09M 100K Mar/2025
Capricor Therapeutics USD -24.98M 17.28M Mar/2025
Cara Therapeutics USD -2.39M 3.16M Mar/2025
Cipla INR 9.77B 6.21B Dec/2025
Dr.Reddys Laboratories INR 13.94B 1.79B Dec/2025
Esperion Therapeutics USD -16.03M 11.51M Sep/2024
Immunic USD -22.81M 756K Jun/2024
Infinity Pharmaceuticals USD -10.12M 1.39M Jun/2023
Minerva Neurosciences USD -4.37M 1.71M Sep/2024
Nektar Therapeutics USD -34.34M 3.68M Sep/2024
Sun Pharmaceuticals INR 40.62B 6.95B Dec/2025
TherapeuticsMD USD -1.77M 699K Sep/2023
UPL INR 16.06B 1.72B Dec/2025